Jefferies Maintains Buy on United Therapeutics, Raises Price Target to $564

Benzinga · 09/02/2025 18:26
Jefferies analyst Roger Song maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $432 to $564.